Skip to content

A Pilot Study to Evaluate a Telepharmacy Intervention to Improve Inhaler Adherence in Veterans With COPD

A Pilot Study to Evaluate a Telepharmacy Intervention to Improve Inhaler Adherence in Veterans With COPD

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01270594
Enrollment
97
Registered
2011-01-05
Start date
2011-01-31
Completion date
2012-04-30
Last updated
2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

Hypothesis: Can a counseling intervention, delivered by a pharmacist, increase inhaler adherence in veterans with COPD who have demonstrated poor inhaler adherence through pharmacy refill records? Veterans who receive who receive daily maintenance inhalers from the William S Middleton Memorial Veterans Hospital Pharmacy and who have a medication possession ratio less than 80% over the previous six months will be invited to participate in the study. This study will randomize 100 participants to a usual care arm or a pharmacist counseling intervention. Final data collection will be six months after randomization to determine if both self-reported and refill record adherence has changed.

Interventions

BEHAVIORALCOPD Inhaler Counseling

The counseling will be performed via telephone by a pharmacist at the William S Middleton Memorial Veterans Hospital. The counseling will include education about inhaled COPD medication, inhaler technique review, reminder tools, and motivational interviewing.

BEHAVIORALUsual Pharmacy Care

The usual care arm will receive standard care from the William S Middleton Memorial Veterans Hospital pharmacists.

Sponsors

William S. Middleton Memorial Veterans Hospital
CollaboratorFED
American Society of Health-System Pharmacists
CollaboratorOTHER
University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female veterans established with the William S. Middleton Memorial Veterans Hospital and associated Community Based Outpatient Clinics * Fill their inhaled COPD medications with the VHA * A diagnosis of COPD and an active prescription for a twice daily long-acting beta-agonist and/or long-acting anticholinergic with or without a prescription for inhaled corticosteroids for at least 4 months. * Non-adherence to at least one COPD medication, a medication possession ratio of less than 80% or over 120% via the pharmacy refill records.

Exclusion criteria

* Patients with a diagnosis or electronic medical record note regarding significant hearing impairment. * Patients with a diagnosis regarding cognitive deficit and activated power of attorney. * Patients who use daily nebulization instead of inhalers for maintenance medication.

Design outcomes

Primary

MeasureTime frameDescription
Adherence to daily inhaled COPD medicationsPrevious six monthsAdherence will be measured by pharmacy refill records and by participant self-report

Secondary

MeasureTime frameDescription
COPD exacerbationsPrevious six monthsParticipants will be asked how many episodes of worsening their COPD has required additional medical care and/or the use of an oral steroid or antibiotic.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026